Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alimena

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Blood|May 15, 1995
Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic featuresM Fizzotti, G Cimino, S Pisegna, et al.
Bone Marrow Transplantation|October 1, 1990
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autograftingP De Fabritiis, A Sandrelli, G Meloni, et al.
Leukemia Research|August 5, 2008
Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposalM Breccia, R Latagliata, L Cannella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemiaE Montefusco, M C Petti, G Alimena, et al.
Leukemia|September 1, 1995
Acute leukemia presenting a variant Ph chromosome with p190 expression, dup 3q and -7, developed after malignant lymphoma treated with alkylating agents and topoisomerase II inhibitorsG Alimena, M Cedrone, M Nanni, et al.
Leukemia|November 13, 2004
Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response statusG Alimena, M Breccia, M Mancini, et al.
Leukemia & Lymphoma|January 1, 1995
Acute myeloid leukemias M2 potentially misdiagnosed as M3 variant French-American-Britain (FAB) subtype: a transitional form?S Fenu, D Carmini, F Mancini, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative StudyA Zaccaria, G Rosti, N Testoni, et al.
Haematologica|July 1, 1990
Long-term remission of T-lymphoid extramedullary blast crisis of chronic myelogenous leukemia following allogeneic bone marrow transplantationE Montefusco, F R Mauro, F Lo Coco, et al.
Leukemia Research|April 1, 2008
Pregnancy in patients with myelodysplastic syndromes (MDS)P Volpicelli, R Latagliata, M Breccia, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Blood|May 15, 1995
Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic featuresM Fizzotti, G Cimino, S Pisegna, et al.
Bone Marrow Transplantation|October 1, 1990
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autograftingP De Fabritiis, A Sandrelli, G Meloni, et al.
Leukemia Research|August 5, 2008
Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposalM Breccia, R Latagliata, L Cannella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemiaE Montefusco, M C Petti, G Alimena, et al.
Leukemia|September 1, 1995
Acute leukemia presenting a variant Ph chromosome with p190 expression, dup 3q and -7, developed after malignant lymphoma treated with alkylating agents and topoisomerase II inhibitorsG Alimena, M Cedrone, M Nanni, et al.
Leukemia|November 13, 2004
Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response statusG Alimena, M Breccia, M Mancini, et al.
Leukemia & Lymphoma|January 1, 1995
Acute myeloid leukemias M2 potentially misdiagnosed as M3 variant French-American-Britain (FAB) subtype: a transitional form?S Fenu, D Carmini, F Mancini, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative StudyA Zaccaria, G Rosti, N Testoni, et al.
Haematologica|July 1, 1990
Long-term remission of T-lymphoid extramedullary blast crisis of chronic myelogenous leukemia following allogeneic bone marrow transplantationE Montefusco, F R Mauro, F Lo Coco, et al.
Leukemia Research|April 1, 2008
Pregnancy in patients with myelodysplastic syndromes (MDS)P Volpicelli, R Latagliata, M Breccia, et al.
Pageof 14